We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Immunoglobulin E Tests Not Always Reliable for Infants

By LabMedica International staff writers
Posted on 02 Jan 2012
Physicians are warned not to rely on allergen-specific immunoglobulin E (IgE) tests for pediatric allergies.

The mere detection of sensitization to an allergen on IgE tests is not always equivalent to a clinical diagnosis, cautioned a clinical report from the American Academy of Pediatrics (AAP).

The advisory from two allergists, Robert Wood of the Johns Hopkins Children's Center (Baltimore, MD, USA) and Scott Sicherer of Mt. More...
Sinai Hospital (New York, NY, USA), urges clinicians to use caution when ordering allergy tests and to avoid making a diagnosis based solely on test results.

Most allergies result in the production of IgE antibodies that are specific to that allergen. A report, published in the January 2012 issue of Pediatrics, offers aid to pediatricians in selecting the appropriate allergy tests, and interpreting the results in the context of a patient history and clinical presentation.

The detailed medical history and tests must be interpreted in the presence of a clinical presentation, the authors noted. For instance, a child who eats eggs without any symptoms does not need to undergo testing for an egg allergy. The same holds true for pollen testing when a child is not physically exposed to a certain pollen.

In vitro allergen-specific immunoglobulin E (sIgE) testing is widely available to physicians, but the report sets out several caveats that physicians need to keep in mind when using these tests and before embarking on immunotherapy.

Both serum sIgE tests and skin-prick tests have similar diagnostic properties with specific pros and cons. Skin-prick tests offer immediate results and are low cost, but they require the availability of rash-free skin.

Serologic tests are not affected by antihistamines or extensive dermatitis, but require a blood sample and cost more.

The report also includes guidance on specific allergies: e.g., for asthma the physician is advised to follow national guidelines and test for indoor allergens (dust mites, mold). There is no current evidence that testing for total IgE will identify specific food allergies. In addition IgE tests are not relevant for many drug reactions. The diagnostic value of serum tests is not well characterized for latex allergies. A localized reaction at an insect bite or sting site does not indicate a risk for anaphylaxis; testing is not warranted.

In vitro allergen-specific immunoglobulin E (sIgE) testing is widely available to physicians, but the report sets out several caveats that physicians need to keep in mind when using these tests and before embarking on immunotherapy.

Related Links:

Johns Hopkins Children's Center
Mt. Sinai Hospital



Gold Member
Veterinary Hematology Analyzer
Exigo H400
Serological Pipet Controller
PIPETBOY GENIUS
New
Pan-Cancer Panel
TruSight Oncology 500
New
Modular Hemostasis Automation Solution
CN Track
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: New research brings hope for improved early detection of pancreatic cancer (Photo courtesy of Adobe Stock)

New Biomarker Panel to Enable Early Detection of Pancreatic Cancer

Pancreatic cancer (PC) has one of the worst prognoses globally, with only 13% of diagnosed patients surviving for five years or more. In Ireland, there are about 900 cases of pancreatic cancer annually,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.